Bra podd
Sveriges mest populära poddar
- Affärsnyheter
- Alternativ hälsa
- Amerikansk fotboll
- Andlighet
- Animering och manga
- Astronomi
- Barn och familj
- Baseball
- Basket
- Berättelser för barn
- Böcker
- Brottning
- Buddhism
- Dagliga nyheter
- Dans och teater
- Design
- Djur
- Dokumentär
- Drama
- Efterprogram
- Entreprenörskap
- Fantasysporter
- Filmhistoria
- Filmintervjuer
- Filmrecensioner
- Filosofi
- Flyg
- Föräldraskap
- Fordon
- Fotboll
- Fritid
- Fysik
- Geovetenskap
- Golf
- Hälsa och motion
- Hantverk
- Hinduism
- Historia
- Hobbies
- Hockey
- Hus och trädgård
- Ideell
- Improvisering
- Investering
- Islam
- Judendom
- Karriär
- Kemi
- Komedi
- Komedifiktion
- Komediintervjuer
- Konst
- Kristendom
- Kurser
- Ledarskap
- Life Science
- Löpning
- Marknadsföring
- Mat
- Matematik
- Medicin
- Mental hälsa
- Mode och skönhet
- Motion
- Musik
- Musikhistoria
- Musikintervjuer
- Musikkommentarer
- Näringslära
- Näringsliv
- Natur
- Naturvetenskap
- Nyheter
- Nyhetskommentarer
- Personliga dagböcker
- Platser och resor
- Poddar
- Politik
- Relationer
- Religion
- Religion och spiritualitet
- Rugby
- Så gör man
- Sällskapsspel
- Samhälle och kultur
- Samhällsvetenskap
- Science fiction
- Sexualitet
- Simning
- Självhjälp
- Skönlitteratur
- Spel
- Sport
- Sportnyheter
- Språkkurs
- Stat och kommun
- Ståupp
- Tekniknyheter
- Teknologi
- Tennis
- TV och film
- TV-recensioner
- Underhållningsnyheter
- Utbildning
- Utbildning för barn
- Verkliga brott
- Vetenskap
- Vildmarken
- Visuell konst
Start / The Long Run with Luke Timmerman
”The Long Run”
Antarctic explorer Ernest Shackleton would appreciate today’s biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Avsnitt
Ep178: Peyton Greenside on ML-Guided Biologics Discovery
13 maj 2025 |
63 min
Peyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.
Ep177: Kevin Parker on Finding Cancer Drug Targets
14 april 2025 |
58 min
Kevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.
Ep176: David Roblin on Building a TechBio Company
31 mars 2025 |
79 min
David Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
16 mars 2025 |
71 min
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
Ep174: Najat Khan on the TechBio Movement
3 mars 2025 |
67 min
Najat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders
11 februari 2025 |
58 min
Robert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders.
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale
27 januari 2025 |
81 min
Mostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale.
Ep171: Ram Aiyar on RNA Editing Medicines
13 januari 2025 |
62 min
Ram Aiyar, CEO of Cambridge, Mass.-based Korro Bio, on RNA editing medicines.
Ep170: David Schenkein on Investing in the Future of Biotech
2 januari 2025 |
60 min
David Schenkein, general partner at GV, on investing in the future of biotech.
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
11 december 2024 |
62 min
Alnylam Pharmaceuticals chief scientific officer Kevin Fitzgerald on the past, present & future of RNA interference medicines.
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
25 november 2024 |
60 min
Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.
Ep167: Leslie Williams on transfer RNA therapies
6 november 2024 |
71 min
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
15 oktober 2024 |
64 min
Chris Garcia, professor at Stanford University and co-founder of several biotech startups, on using protein engineering to advance new treatments for cancer and autoimmune diseases.
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
26 september 2024 |
63 min
Zach Hornby, CEO of San Diego-based Boundless Bio, on tackling cancer drug resistance.
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
5 september 2024 |
57 min
Ted Love, chairman of BIO, and Dr. Alan Anderson, executive director of Sickle Forward, on how to improve quality of life for sickle cell disease patients around the world.
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
14 augusti 2024 |
68 min
Sarah Boyce, CEO of San Diego-based Avidity Biosciences, on RNA medicines for rare muscle diseases.
Ep162: Sean McClain on AI for Biologic Drug Discovery
16 juli 2024 |
66 min
Sean McClain, CEO of Absci, on using AI to speed up biologic drug discovery.
Ep161: Jeff Stein on a Long-Lasting Flu Drug
1 juli 2024 |
69 min
Jeff Stein, CEO of San Diego-based Cidara Therapeutics, on a long-lasting drug against flu.
Ep160: Abe Ceesay on Precision Neuroscience
17 juni 2024 |
69 min
Abe Ceesay, CEO of Boston-based Rapport Therapeutics, on a precision medicine approach to neuroscience drug discovery.
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
3 juni 2024 |
67 min
Jimi Olaghere is one of the first patients to have been functionally cured of sickle cell disease with a CRISPR gene-edited cell therapy.
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
20 maj 2024 |
61 min
David Younger and Randolph Lopez, co-founders of A-Alpha Bio, on using synthetic biology and AI to discover new biologic drugs.
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
1 maj 2024 |
57 min
Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.
Ep156: David Liu on New Tools and Techniques for Biology
16 april 2024 |
113 min
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's
6 mars 2024 |
63 min
Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
9 februari 2024 |
63 min
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
Ep153: Rick Young on Studying Gene Expression for Drug Discovery
22 januari 2024 |
62 min
Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.
Ep152: Jens Eckstein on Investing in Healthy Aging
10 januari 2024 |
65 min
Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
26 december 2023 |
64 min
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
13 december 2023 |
64 min
Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.
Ep149: Nancy Stagliano on Precision Neuroscience
29 november 2023 |
62 min
Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.
Ep148: Diana Brainard on the Fight Against Infectious Disease
13 november 2023 |
63 min
Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.
Ep147: Reid Huber on Investing in the Future of Medicine
1 november 2023 |
69 min
Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.
Ep146: Jeff Huber on Life in Tech and Biotech
17 oktober 2023 |
107 min
Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
3 oktober 2023 |
67 min
Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.
Ep144: Turning the Tables, Rob Perez Interviews Me
19 september 2023 |
65 min
Turning the Tables, Rob Perez Interviews Me
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
6 september 2023 |
70 min
Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech Founders
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
24 augusti 2023 |
56 min
Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
8 augusti 2023 |
70 min
Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
24 juli 2023 |
63 min
Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.
Ep139: Kevin Conroy on Early Detection of Cancer
10 juli 2023 |
68 min
Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.
Ep138: Jodie Morrison on Becoming a Biotech CEO
27 juni 2023 |
60 min
Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.
Ep137: Aaron Ring on Immunotherapy for Cancer & More
14 juni 2023 |
57 min
Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.
Ep136: Deborah Palestrant on Building Biotech Startups
30 maj 2023 |
53 min
Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.
Ep135: John Maraganore on Developing a New Class of Medicines
8 maj 2023 |
64 min
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
24 april 2023 |
76 min
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
12 april 2023 |
71 min
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.
Ep132: Eric Dobmeier on Treating Kidney Disease
28 mars 2023 |
66 min
Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.
Ep131: Ryan Watts on Neuroscience Drug R&D
14 mars 2023 |
66 min
Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
28 februari 2023 |
69 min
David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
14 februari 2023 |
72 min
Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
1 februari 2023 |
61 min
Rick Berke, co-founder and executive editor of STAT, on building a biotech journalism outlet to last.
Ep127: Jeb Keiper on Computational Drug Discovery
20 januari 2023 |
70 min
Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.
Ep126: DA Wallach on Becoming a Biotech VC
3 januari 2023 |
72 min
DA Wallach, founder and general partner of TIME Bioventures, on becoming a biotech venture investor.
Ep125: Barry Greene on a New Drug for Depression
19 december 2022 |
65 min
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
8 november 2022 |
70 min
Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
27 oktober 2022 |
75 min
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
11 oktober 2022 |
60 min
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
26 september 2022 |
64 min
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.
Ep120: Tim Lu on Gene Circuits for Cell Therapy
7 september 2022 |
64 min
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
22 augusti 2022 |
63 min
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
8 augusti 2022 |
68 min
Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World
11 juli 2022 |
61 min
Dr. Sanduk Ruit of the Tilganga Institute in Kathmandu on restoring eyesight with affordable cataract surgery for the developing world.
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience
22 juni 2022 |
59 min
Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, on precision neuroscience drug development.
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
7 juni 2022 |
59 min
Rahul Singhvi, CEO of Resilience, on rethinking the model for manufacturing of advanced biologics, gene and cell therapies.
Ep114: Chris Gibson on Industrializing Drug Discovery
23 maj 2022 |
67 min
Chris Gibson, co-founder and CEO of Recursion, on using new tools to industrialize drug discovery.
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs
9 maj 2022 |
40 min
Lewis Cantley and Siddhartha Mukherjee, co-founders of Faeth Therapeutics, on fighting cancer with food and drug combinations.
Ep112: Bernat Olle on Microbiome Therapeutics
18 april 2022 |
66 min
Bernat Olle, CEO of Vedanta Biosciences, on developing microbiome therapeutics.
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
14 mars 2022 |
63 min
Ray Stevens, CEO of ShouTi, on structural biology driven drug discovery.
Ep110: Michele Andrasik on Making Clinical Trials More Diverse
1 mars 2022 |
67 min
Michele Andrasik, a clinical health psychologist at the Fred Hutchinson Cancer Research Center, on improving community outreach and diversity in clinical trials.
Ep109: Derrell Porter on Cell Therapy Commercialization
15 februari 2022 |
69 min
Derrell Porter, CEO of CellEvolve, on a new approach to commercializing cell therapies.
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
31 januari 2022 |
71 min
Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.
Ep107: Bassil Dahiyat on Antibody Engineering & Company Building
11 januari 2022 |
64 min
Bassil Dahiyat of Xencor on antibody engineering and company building.
Ep106: Vineeta Agarwala on Health Data & VC Investing
20 december 2021 |
71 min
Vineeta Agarwala, general partner with Andreesen Horowitz's bio fund, on investing in therapeutics, diagnostics and digital health.
Ep105: Nello Mainolfi on Targeted Protein Degraders
6 december 2021 |
68 min
Nello Mainolfi, CEO of Kymera Therapeutics, on targeted protein degrading small molecule drugs.
Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity
1 december 2021 |
67 min
Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.
Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer
23 november 2021 |
61 min
Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.
Ep102: David Baltimore Reflects on a Life in Science
8 november 2021 |
72 min
David Baltimore, professor emeritus at Caltech, reflects on a life in science.
Ep101: Tony Kulesa on Fostering Founder-Led Biotechs
26 oktober 2021 |
73 min
Tony Kulesa of Petri.bio on fostering founder-led biotech companies
Ep100: Christian Henry on Long Read DNA Sequencing
13 oktober 2021 |
70 min
Christian Henry, CEO of PacBio, on long read DNA sequencing applications.
Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations
27 september 2021 |
69 min
Keolu Fox, assistant professor at UC San Diego, on genome sequencing of indigenous populations.
Ep98: Mara Aspinall on Diagnostics and COVID-19
13 september 2021 |
68 min
Mara Aspinall of Arizona State University on diagnostics and COVID-19.
Ep97: John Evans on Base Edited Therapeutics
7 september 2021 |
72 min
John Evans, CEO of Beam Therapeutics, on base editing technology for therapeutics.
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
9 augusti 2021 |
67 min
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader
26 juli 2021 |
59 min
Sue Desmond-Hellmann on becoming a physician-scientist and biotech industry leader.
Ep94: Jenny Rooke on Investing in Biotech Tools
19 juli 2021 |
71 min
Jenny Rooke of Genoa Ventures on investing in biology & technology.
Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists
14 juni 2021 |
93 min
Ep93: Jay Bradner of Novartis & Andy Plump of Takeda on Mentoring Young Scientists
Ep92: Brad Gray on Spatial Biology
1 juni 2021 |
72 min
NanoString Technologies CEO Brad Gray on tools for spatial biology.
Ep91: Daphne Zohar on Biotech Entrepreneurship
3 maj 2021 |
52 min
Daphne Zohar, CEO of Puretech Health, on starting biotech companies.
Ep90: James Sabry on Partnering Amid Scientific Abundance
19 april 2021 |
61 min
James Sabry, global head of pharma partnering for Roche, on partnering in a time of scientific abundance.
Ep89: Emily Leproust on DNA Synthesis at Scale
29 mars 2021 |
65 min
Emily Leproust, co-founder and CEO of Twist Bioscience, on DNA Synthesis at Scale
Ep88: Amy DuRoss on software and logistics for cell and gene therapy
15 mars 2021 |
65 min
Amy DuRoss, CEO of Vineti, on software and logistics for cell and gene therapy.
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
1 mars 2021 |
49 min
Bob Nelsen of ARCH Venture Partners on long-term trends in biotech investing.
Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease
9 februari 2021 |
69 min
Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.
Ep85: Luhan Yang on CRISPR Editing for Organ Transplants
20 januari 2021 |
47 min
Luhan Yang, CEO of Qihan Bio, on CRISPR editing for organ transplants.
Ep84: Steve Paul on Treatments for Mental Health
22 december 2020 |
69 min
Steve Paul, CEO of Karuna Therapeutics, on neuropsychiatric drug development.
Ep83: David Lee on Impact in Pharmaceuticals
14 december 2020 |
58 min
David Lee, CEO of Servier Pharma, on a nonprofit model.
Ep82: Andrew Farnum on Medicines From Unusual Traits
23 november 2020 |
59 min
Andrew Farnum, CEO of Variant Bio, on drug discovery based on rare genetic traits.
Ep81: Simba Gill on Microbiome Therapies
12 november 2020 |
67 min
Simba Gill, CEO of Evelo Biosciences, on microbiome therapies.
Ep80: Peter Kolchinsky on Pharma's Soul
28 oktober 2020 |
52 min
Peter Kolchinsky of RA Capital on making drugs affordable, and keeping incentives for drug discovery.
Ep79: Daphne Koller on Machine Learning for Drug Discovery
26 oktober 2020 |
70 min
Daphne Koller, CEO of insitro, on machine learning for drug discovery
Ep78: Pearl Huang on Exoneural Cancer Biology
13 oktober 2020 |
66 min
Pearl Huang, CEO of Cygnal Therapeutics, on Exoneural Cancer Biology
Ep77: Jennifer Petter on Drugging RNA Targets
29 september 2020 |
81 min
Jennifer Petter, CSO of Arrakis Therapeutics, on small molecule drugs for RNA targets
Ep76: Otello Stampacchia on Becoming a Biotech VC
8 september 2020 |
69 min
Otello Stampacchia on becoming a biotech venture capitalist.
Ep75: Rosana Kapeller on Drugging the Repeatome
10 augusti 2020 |
64 min
Rosana Kapeller, CEO of ROME Therapeutics
Ep74: Abe Ceesay's Path to Leadership
21 juli 2020 |
76 min
Abe Ceesay, CEO of Tiburio Therapeutics
Ep73: Kevin Ness on Digital Genome Engineering
7 juli 2020 |
65 min
Ep73: Kevin Ness on Digital Genome Engineering by Timmerman Report
Conversation on Race with Ted Love
13 juni 2020 |
35 min
Ted Love, CEO of Global Blood Therapeutics, on Racial Inequity
Ep71: Andy Plump
10 juni 2020 |
42 min
Takeda R&D president Andy Plump on fighting COVID19 and racism.
Ep70: Nina Kjellson
26 maj 2020 |
65 min
Nina Kjellson forging a path in biotech venture capital.
Vaccine Strategy with Larry Corey
14 maj 2020 |
35 min
Ep69 of The Long Run with virologist Larry Corey
Ep68: Emma Hodcroft
30 april 2020 |
41 min
Emma Hodcroft on NextStrain and viral evolution
Ep67: George Scangos
17 april 2020 |
36 min
George Scangos of VIR on neutralizing antibodies for SARS-CoV-2
Ep66: Mike Pellini
5 april 2020 |
38 min
Mike Pellini on COVID19 diagnostic testing.
Ep65: Alexis Borisy & Melanie Nallicheri
24 mars 2020 |
58 min
Leaders of EQRx, a company aspiring to make novel drugs at low prices.
Ep64: Isabella de la Houssaye
9 mars 2020 |
49 min
Isabella is a Stage 4 lung cancer patient on a mission.
Ep63: Jeremy Levin
25 februari 2020 |
59 min
Jeremy Levin, chairman of BIO, on the perilous moment in politics.
Ep62: Jane Grogan
11 februari 2020 |
56 min
Jane Grogan, CSO of Arsenal Bio, on programmable cell therapies.
Ep61: Sanjiv Patel
27 januari 2020 |
65 min
Sanjiv Patel, CEO of Relay Therapeutics, computational drug discovery company.
Ep60: Tim Mayleben
14 januari 2020 |
70 min
Tim Mayleben, CEO of Esperion Therapeutics, on cholesterol-lowering meds.
Ep59: David Baker
30 december 2019 |
62 min
David Baker, University of Washington protein designer.
Ep58: Jigar Raythatha
3 december 2019 |
72 min
Jigar Raythatha of Constellation Pharma on epigenetic drug development.
Ep57: John Alam
26 november 2019 |
81 min
John Alam on Alzheimer's drug development.
Ep56: Tim Springer
13 november 2019 |
65 min
Tim Springer of Harvard Medical School on his career in science and biotech.
Ep55: John Hawkins & Jim Geraghty
29 oktober 2019 |
67 min
Discussion on the new Henri Termeer biography.
Ep54: Aoife Brennan
15 oktober 2019 |
66 min
CEO of Synlogic on developing synthetic biology-based drugs.
Ep53: Phil Sharp
1 oktober 2019 |
64 min
MIT biologist Phil Sharp on his early career.
Ep52: Bruce Carter
18 september 2019 |
46 min
Bruce Carter on developing a new tuberculosis drug.
Ep51: Ted Love
3 september 2019 |
63 min
Ted Love of Global Blood Therapeutics on a new drug for sickle cell disease
Ep50: Joel Marcus
20 augusti 2019 |
65 min
Joel Marcus, chairman of Alexandria Real Estate Equities, on building in biotech clusters.
Ep49: Janelle Anderson
8 augusti 2019 |
65 min
Janelle Anderson on venture capital and off-the-shelf cell therapy at Century Therapeutics
Ep48: Cindy Perettie
11 juli 2019 |
62 min
Cindy Perettie of Foundation Medicine on genomic analysis for cancer.
Ep47: Laura Shawver
2 juli 2019 |
71 min
Laura Shawver on synthetic biology engineering of cancer drugs.
Ep46: Liz O'Day
12 juni 2019 |
67 min
Liz O'Day on metabolite signatures for predicting cancer drug response.
Ep45: Jay Bradner
22 maj 2019 |
71 min
Jay Bradner, president of Novartis Institutes for Biomedical Research, on his journey from open biology advocate to pharma leadership.
Ep44: Sheila Gujrathi
9 maj 2019 |
72 min
Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer
Ep43: Jeff Jonas
24 april 2019 |
72 min
Sage Therapeutics CEO on psychiatric drug development.
Ep42: Carolyn Bertozzi
9 april 2019 |
69 min
Carolyn Bertozzi on becoming a chemical biologist/glycobiologist.
Ep41: Bob Langer
27 mars 2019 |
67 min
MIT's Bob Langer on his journey in science and entrepreneurship.
Ep40: Serge Saxonov
13 mars 2019 |
70 min
Serge Saxonov on the single-cell analysis revolution.
Ep39: Julia Owens
26 februari 2019 |
70 min
Julia Owens on pivoting, more than once, in a biotech startup.
Ep38: Harlan and Chad Robins (Take 2)
13 februari 2019 |
70 min
The co-founders of Adaptive Biotechnologies on immune sequencing.
Ep37: Bonnie Anderson
29 januari 2019 |
70 min
Bonnie Anderson of Veracyte on genomic diagnostics.
Ep36: George Scangos
15 januari 2019 |
67 min
George Scangos on building an infectious disease company
Ep35: Karen Akinsanya
2 januari 2019 |
60 min
Karen Akinsanya of Schrodinger on computational drug discovery
Ep34: Ron Renaud
26 december 2018 |
75 min
Ron Renaud on developing messenger RNA therapies.
Ep33: Krishna Yeshwant
11 december 2018 |
73 min
Krishna Yeshwant of GV on life at the intersection of tech and biotech.
Ep32: Ned David
28 november 2018 |
60 min
Ned David on extending human healthspan.
Ep31: Julie Sunderland
14 november 2018 |
59 min
Julie Sunderland on VC investing at the nexus of tech and biotech.
Ep30: Barbara Weber
31 oktober 2018 |
60 min
Barbara Weber on synthetic lethal cancer drug discovery
Ep29: John Wilbanks
16 oktober 2018 |
70 min
John Wilbanks on making it easy to share biological data.
Ep28: Sabah Oney
2 oktober 2018 |
69 min
Sabah Oney on becoming a scientific business executive.
Ep27: Amy Abernethy
18 september 2018 |
58 min
Amy Abernethy on making EHRs useful for drug development.
Ep26: Meg Tirrell
5 september 2018 |
55 min
Meg Tirrell on covering biotech on TV.
Ep25: Thong Le
21 augusti 2018 |
63 min
Thong Le on building startups to suit pharma needs.
Ep24: Ankit Mahadevia
7 augusti 2018 |
59 min
Ankit Mahadevia on the antibiotic opportunity
Ep23: Chris Garabedian
24 juli 2018 |
63 min
Chris Garabedian on the "middle market" of biotech VC.
Ep22: Vicki Sato (Take 2)
9 juli 2018 |
65 min
Vicki Sato on her career in biotech.
Ep21: Tony Coles
21 juni 2018 |
62 min
Tony Coles on neurodegenerative drug discovery and inclusive leadership.
Ep20: Rob Perez
4 juni 2018 |
64 min
Ep20: Rob Perez by Timmerman Report
Ep19: Chip Clark
9 maj 2018 |
65 min
Ep19: Chip Clark by Timmerman Report
Ep18: Ethan Perlstein
9 maj 2018 |
64 min
Ep18: Ethan Perlstein by Timmerman Report
Ep17: Alice Zhang
24 april 2018 |
58 min
Ep17: Alice Zhang by Timmerman Report
Ep14: Michael Gilman
13 mars 2018 |
61 min
Michael Gilman on becoming an entrepreneur.
Ep13: Bruce Booth
28 februari 2018 |
58 min
Bruce Booth on human capital
Ep12: David Schenkein
13 februari 2018 |
59 min
Agios CEO David Schenkein on building a cancer R&D engine to last.
Ep11: Stephane Bancel
31 januari 2018 |
66 min
Stephane Bancel, CEO of Moderna Therapeutics, on his influences.
Ep10: Abbie Celniker
16 januari 2018 |
52 min
Abbie Celniker of Third Rock Ventures on her career, and chipping away at gender inequities in biotech.
Ep9: Bob More
2 januari 2018 |
49 min
Bob More on biotech venture capital
Ep8: BioMarin History
20 december 2017 |
62 min
Daniel Levine & Dan Maher discuss their book "A Rare Breed."
Ep7: Steve Graham
5 december 2017 |
58 min
Steve Graham on racism in Corporate America.
Ep6: Steve Holtzman
29 november 2017 |
60 min
Ep6: Steve Holtzman of Decibel Therapeutics on political activism among biotech CEOs.
Ep5: Elias Zerhouni
8 november 2017 |
47 min
Elias Zerhouni, president of R&D at Sanofi, on immigration in science and the importance of government science funding.
Ep4: Richard Pops
24 oktober 2017 |
57 min
Alkermes CEO Richard Pops on fighting the opioid painkiller crisis.
Ep3: George Yancopoulos
10 oktober 2017 |
58 min
Interview with Regeneron president and CSO George Yancopoulos
Ep2: Katrine Bosley
27 september 2017 |
57 min
Ep. 2 of The Long Run With Luke Timmerman. Interview with Katrine Bosley, CEO of Editas Medicine.
Ep1: John Maraganore
13 september 2017 |
59 min
Ep. 1 of The Long Run, a biotech podcast with Luke Timmerman. Conversation with Alnylam Pharmaceuticals CEO John Maraganore.
Fler poddar
Podcasten The Long Run with Luke Timmerman är skapad av Timmerman Report. Podcastens innehåll och bilderna på den här sidan hämtas med hjälp av det offentliga podcastflödet (RSS).
00:00
-00:00
Vad är en podd?
En liten tjänst av I'm With Friends. Finns även på engelska.